CHUQ

Running trials

• Recruiting

  Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  NCT05489887· Phase 2· Source

• Recruiting

  DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  NCT04696029· Phase 2· Source

• Active, not recruiting

  Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  NCT04301843· Phase 2· Source

• Recruiting

  Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy

  NCT04100174· Phase 2· Source

• Active, not recruiting

  Neuroblastoma Maintenance Therapy Trial

  NCT02679144· Phase 2· Source

• Recruiting

  Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  NCT02559778· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers4 recruiting
• Neuroblastoma2 recruiting
• Prostate cancer1 recruiting

Researchers

No researcher is linked here yet.